|
DEM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.83760000338884E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.07770000001839E-06 |
| Normal-vs-Stage2 |
2.08859999999422E-05 |
| Normal-vs-Stage3 |
1.55741999999792E-05 |
| Normal-vs-Stage4 |
9.19210000338566E-08 |
| Stage1-vs-Stage2 |
4.871800E-01 |
| Stage1-vs-Stage3 |
6.300200E-01 |
| Stage1-vs-Stage4 |
4.071800E-02 |
| Stage2-vs-Stage3 |
7.729600E-01 |
| Stage2-vs-Stage4 |
2.867600E-01 |
| Stage3-vs-Stage4 |
1.458620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73570000039369E-07 |
| Normal-vs-AfricanAmerican |
1.704330E-03 |
| Normal-vs-Asian |
2.924300E-02 |
| Caucasian-vs-AfricanAmerican |
9.213000E-01 |
| Caucasian-vs-Asian |
5.516000E-02 |
| AfricanAmerican-vs-Asian |
2.797200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8802000000262E-06 |
| Normal-vs-Female |
8.81920000361802E-08 |
| Male-vs-Female |
8.589200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.8823699999948E-05 |
| Normal-vs-Age(41-60Yrs) |
3.98970000037302E-07 |
| Normal-vs-Age(61-80Yrs) |
5.65290000364982E-08 |
| Normal-vs-Age(81-100Yrs) |
1.958470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.010200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.543600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.494200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.804800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.184000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.547600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.926000E-01 |
| Classical-VS-Follicular |
1.95930000002065E-06 |
| Classical-VS-Other |
6.456000E-01 |
| Classical-VS-Normal |
1.63046999999139E-05 |
| Tall-VS-Follicular |
8.575600E-03 |
| Tall-VS-Other |
6.273600E-01 |
| Tall-VS-Normal |
5.479100E-03 |
| Follicular-VS-Other |
5.259000E-01 |
| Follicular-VS-Normal |
6.52629950081973E-10 |
| Other-VS-Normal |
1.670950E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.5311999997153E-07 |
| Normal-vs-N1 |
3.30690000005518E-06 |
| N0-vs-N1 |
3.089800E-01 |
|
|
